Article
c-Met: structure, functions and potential for therapeutic inhibition.
Cancer metastasis reviews - 1 Dec 2003
Ma Patrick C, Maulik Gautam, Christensen James, Salgia Ravi
Abstract excerpt
Studies on signal transduction pathways have generated various promising molecular targets for therapeutic inhibition in cancer therapy. Receptor tyrosine kinases represent an important class of such therapeutic targets. c-Met is a receptor tyrosine kinase that has been shown to be overexpressed and/or mutated in a variety of malignancies. A number of c-Met activating mutations, many of which are located in the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
